IL-21 is critical for GVHD in a mouse model

A Meguro1, K Ozaki, I Oh

  • 1Division of Hematology, Department of Medicine, Jichi Medical University Tochigi, Tochigi, Japan.

Bone Marrow Transplantation
|September 1, 2009
PubMed
Summary

Interleukin-21 (IL-21) blockade significantly reduces graft-versus-host disease (GVHD) severity and mortality in mice. Blocking IL-21 signaling offers a potential new strategy for preventing GVHD after bone marrow transplantation (BMT).

Related Concept Videos